Hindu Business Line I Hyderabad, 8 Apr, 2021: Transasia Bio-Medicals sets up IVD manufacturing facility in Vizag

In-vitro diagnostic company, Transasia Bio-Medicals Ltd, has set up a ₹30-crore medical devices manufacturing plant at the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam.

The plant was formally inaugurated on Wednesday with product rollouts expected in early September.

"The largest-of-its-kind facility in Asia spread over 35,000 sq ft will manufacture ErbaLisa Covid-19 IgG ELISA test kits, RT-PCR kits and rapid test kits for India and other emerging markets," Suresh Vazirani, Founder and Chairman, Transasia-Erba International Group of Companies, told BusinessLine on Thursday.

This is the fifth manufacturing facility for the Mumbai-based company along with plants in Baddi, Daman, Sikkim and Mumbai.

Fifth facility

The facility, with an annual capacity of two million molecular and serology test kits, has face recognition system, cold room, storage area, clean rooms of BSL-II/BSL-III grade, large lyophilisers, protein purification equipment, advanced QC equipment and automated machines. It has the capacity to produce six lakh Elisa-based antibody detection test kits per day besides RT-PCR and rapid test kits.

It plans to manufacture testing kits for other immunology products as well. “The facility will play a key role in import substitution of medical devices. It will have the flexibility to scale up manufacturing capabilities on demand, while driving greater operational efficiency," Vazirani said. "To meet the growing demand, Transasia will significantly invest in R&D and manpower at the facility for its immunology products with total hiring estimated at 500 employees as of now," he said. The company had clocked a revenue of 1,300 crore in the financial year ended March, 2021.